UPDATED May 13, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CRL | US$228.41 | -2.9% | 18.7% | US$11.8b | US$265.60 | PE26.5x | E13.6% | n/a | ||
BPMC | US$108.05 | 1.7% | 96.0% | US$6.8b | US$118.13 | PS24x | E66.4% | n/a | ||
NCNA | US$3.73 | -3.9% | -81.2% | US$7.8m | US$119.83 | PB0.4x | E41.4% | n/a | ||
YCBD | US$0.69 | -19.4% | -66.3% | US$2.1m | US$2.00 | PB0.3x | E107.1% | n/a | ||
SONN | US$1.81 | -2.7% | -63.2% | US$5.6m | US$12.50 | PS43x | E-24.8% | n/a | ||
TXMD | US$2.08 | 6.1% | -52.6% | US$24.0m | n/a | PS20x | n/a | n/a | ||
CMRA | US$0.021 | 0% | -97.0% | US$651.6k | n/a | PE-0.07x | n/a | n/a | ||
GERN | US$3.74 | 0.3% | 23.0% | US$2.2b | US$6.07 | PS4266x | E64.9% | n/a | ||
MYMD | US$2.51 | -17.9% | -95.6% | US$5.4m | n/a | PB0.4x | n/a | n/a | ||
PHIO | US$0.69 | -21.3% | -79.5% | US$3.2m | US$4.00 | PB0.6x | n/a | n/a |